Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
training activities, secondments and transferable-skills development; A challenging and translational research project at the interface of computational biomarker discovery, rare disease biology and clinical
-
to conduct research activities in the field of Brain-Computer Interfaces, in the scope of the project “BCI4ALL”, co-funded by national funds through the Portuguese Foundation for Science and Technology, I.P
-
Field Computer science Engineering Information science Technology Researcher Profile Recognised Researcher (R2) Application Deadline 31 Dec 2026 - 23:59 (UTC) Country Japan Type of Contract Permanent Job
-
). Experience with conducting human-subjects experiments, especially involving neuroscience, biomechanics, human-computer interaction, or brain-machine interfaces. Experience with dynamic modeling, including
-
Deadline 5 Oct 2026 - 21:59 (UTC) Country Netherlands Type of Contract Temporary Job Status Not Applicable Hours Per Week 36.0 Is the job funded through the EU Research Framework Programme? Not funded by a
-
» Mechanical engineering Engineering » Industrial engineering Computer science » Cybernetics Researcher Profile First Stage Researcher (R1) Positions PhD Positions Application Deadline 1 Oct 2026 - 23:59 (Europe
-
network “Heart–Brain Interfaces.” The creation of an Inserm Chair dedicated to the heart–brain interface will actively contribute to structuring this emerging field, in line with Inserm’s transversal
-
) Application Deadline 5 Oct 2026 - 21:59 (UTC) Country Netherlands Type of Contract Temporary Job Status Not Applicable Hours Per Week 36.0 Is the job funded through the EU Research Framework Programme? Not
-
, commensurate with career stage. Preferred Qualifications Research program on oral squamous cell carcinoma, head and neck squamous cell carcinoma, salivary gland tumors, odontogenic tumors, or oral premalignant
-
management and software development activities, ensuring alignment of technology investments and delivery models with organisational strategy and future clinical trials requirements. The Head of Data and